Gene · 389421
NIH grants1,664
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 1,664
Download this page as JSON| Grant | Title | LIN28B papers | Newest fiscal year |
|---|---|---|---|
| R01CA190378 | The Notch signaling in prostate homeostasis and carcinogenesis | 1 | 2019 |
| R01CA190415 | The epigenetic mechanism of long non-coding RNA in cancer | 1 | 2019 |
| R01CA191785 | Molecular cancer therapy targeting HuR-ARE interaction | 1 | 2019 |
| R01CA196228 | The Role of post-translational activation of Myc in pancreatic cancer | 1 | 2019 |
| R01CA197964 | Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor | 1 | 2019 |
| R01CA214567 | Isozyme-selective ALDH Inhibitors for Sensitizing Ovarian Cancer Stem-like Cells to Chemotherapy | 1 | 2019 |
| R01DK068348 | MicroRNAs and hematopoietic differentiation | 1 | 2019 |
| R01DK107310 | The Role of Stem Cell Derived Microvesicles in Cholestatic Liver Injury | 1 | 2019 |
| R01DK107437 | Molecular Mechanisms of Insulin Resistance Associated Loci | 1 | 2019 |
| R01DK107868 | SIRT6 and lysine fatty acylation in macrophage inflammation | 1 | 2019 |
| R01ES015359 | THE CHARGE STUDY: CHILDHOOD AUTISM RISKS FROM GENETICS AND THE ENVIRONMENT - ADMINISTRATIVE SUPPLEMENT | 1 | 2019 |
| R01EY024986 | Regeneration of rod photoreceptors from Muller glial cells in adult mouse retina | 1 | 2019 |
| R01GM037949 | Mobile Group II Introns and Their Reverse Transcriptases | 1 | 2019 |
| R01GM066868 | Characterizing novel functions of conserved NIMA family kinases | 1 | 2019 |
| R01GM084947 | Drosophila Transgenic RNAi Resource Project | 1 | 2019 |
| R01GM110064 | TFIIH and Transcription Regulation | 1 | 2019 |
| R01HD057194 | Exome Variants Underlying Weight Gain from Adolescence to Adulthood | 1 | 2019 |
| R01HD084542 | Metabolic Control of Puberty: Epigenetic Links | 1 | 2019 |
| R01HL125816 | Microbial triggers and molecular mechanisms of Th17 mediated airway inflammation-Resubmission-1 | 1 | 2019 |
| R01HL133678 | An LXR protein interaction network controlling macrophage lipid transporter expression in response to inflammatory-lipid crosstalk | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/389421/grants?page=36